Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Trajectories of cognitive decline in Alzheimer's disease.

Wilkosz PA, Seltman HJ, Devlin B, Weamer EA, Lopez OL, DeKosky ST, Sweet RA.

Int Psychogeriatr. 2010 Mar;22(2):281-90. doi: 10.1017/S1041610209991001. Epub 2009 Sep 28.

2.

A Bayesian model of psychosis symptom trajectory in Alzheimer's disease.

Seltman HJ, Mitchell S, Sweet RA.

Int J Geriatr Psychiatry. 2016 Feb;31(2):204-10. doi: 10.1002/gps.4326. Epub 2015 Jul 27.

3.

Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.

Amieva H, Mokri H, Le Goff M, Meillon C, Jacqmin-Gadda H, Foubert-Samier A, Orgogozo JM, Stern Y, Dartigues JF.

Brain. 2014 Apr;137(Pt 4):1167-75. doi: 10.1093/brain/awu035. Epub 2014 Feb 27.

PMID:
24578544
4.

Education and trajectories of cognitive decline over 9 years in very old people: methods and risk analysis.

Muniz-Terrera G, Matthews F, Dening T, Huppert FA, Brayne C; CC75C Group..

Age Ageing. 2009 May;38(3):277-82. doi: 10.1093/ageing/afp004. Epub 2009 Feb 28.

PMID:
19252209
5.

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.

Neurology. 1998 Aug;51(2):351-7.

PMID:
9710002
6.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
7.

Gender differences on a brief measure of cognitive functioning in Alzheimer's disease.

Buckwalter JG, Sobel E, Dunn ME, Diz MM, Henderson VW.

Arch Neurol. 1993 Jul;50(7):757-60.

PMID:
8323481
8.

Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.

Harwood DG, Sultzer DL, Wheatley MV.

Neuropsychiatry Neuropsychol Behav Neurol. 2000 Apr;13(2):83-8.

PMID:
10780626
9.

Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study.

Emanuel JE, Lopez OL, Houck PR, Becker JT, Weamer EA, Demichele-Sweet MA, Kuller L, Sweet RA.

Am J Geriatr Psychiatry. 2011 Feb;19(2):160-8. doi: 10.1097/JGP.0b013e3181e446c8.

10.

A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.

Suh GH, Ju YS, Yeon BK, Shah A.

Int J Geriatr Psychiatry. 2004 Sep;19(9):817-24.

PMID:
15352138
11.

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.

Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA; AIBL Research Group..

Int Psychogeriatr. 2012 Feb;24(2):197-204. doi: 10.1017/S1041610211001335. Epub 2011 Jul 13.

PMID:
21749739
12.

A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment.

Yu L, Boyle P, Wilson RS, Segawa E, Leurgans S, De Jager PL, Bennett DA.

Neuroepidemiology. 2012;39(2):73-83. doi: 10.1159/000339365. Epub 2012 Jul 17.

13.

Does executive impairment define a frontal variant of Alzheimer's disease?

Woodward M, Brodaty H, Boundy K, Ames D, Blanch G, Balshaw R; PRIME Study Group..

Int Psychogeriatr. 2010 Dec;22(8):1280-90. doi: 10.1017/S1041610210001596. Epub 2010 Aug 19.

PMID:
20719041
14.

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.

Psychol Med. 2009 Nov;39(11):1907-11. doi: 10.1017/S0033291709005492. Epub 2009 Apr 1.

PMID:
19335933
15.

Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.

Roselli F, Tartaglione B, Federico F, Lepore V, Defazio G, Livrea P.

Clin Neurol Neurosurg. 2009 May;111(4):327-30. doi: 10.1016/j.clineuro.2008.10.006. Epub 2008 Nov 25.

PMID:
19036496
16.

Longitudinal changes in awareness over 36 months in patients with mild Alzheimer's disease.

Vogel A, Waldorff FB, Waldemar G.

Int Psychogeriatr. 2015 Jan;27(1):95-102. doi: 10.1017/S1041610214001562. Epub 2014 Jul 30.

PMID:
25075811
17.

One size fits all? Why we need more sophisticated analytical methods in the explanation of trajectories of cognition in older age and their potential risk factors.

Terrera GM, Brayne C, Matthews F; CC75C Study Collaboration Group..

Int Psychogeriatr. 2010 Mar;22(2):291-9. doi: 10.1017/S1041610209990937. Epub 2009 Nov 12.

PMID:
19906326
18.

[Noncognitive symptoms in Alzheimer's disease. A study of 150 community-dwelling patients using a questionnaire completed by the caregiver].

Derouesné C, Piquard A, Thibault S, Baudouin-Madec V, Lacomblez L.

Rev Neurol (Paris). 2001 Feb;157(2):162-77. French.

PMID:
11283463
19.

Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.

Leoutsakos JM, Forrester SN, Corcoran CD, Norton MC, Rabins PV, Steinberg MI, Tschanz JT, Lyketsos CG.

Int J Geriatr Psychiatry. 2015 Aug;30(8):824-32. doi: 10.1002/gps.4221. Epub 2014 Nov 3.

20.

Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.

Chui HC, Lyness SA, Sobel E, Schneider LS.

Arch Neurol. 1994 Jul;51(7):676-81.

PMID:
8018040

Supplemental Content

Support Center